Kalim, Hanna H.

HRN: 29-17-00  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/16/2026
06/25/2026
PO
8.5ML
TID
AMOEBIASIS
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamIntra-abdominalProphylaxis    Compliance to guidelines: